Document is current
Any future updates will be listed below
-
Authors
Morrow, April https://orcid.org/0000-0003-0714-363X
Parkinson, Bonny
Kang, Yoon-Jung
Hogden, Emily
Canfell, Karen
Taylor, Natalie
-
Funding
Funding for this research was provided by:
Translational Cancer Research Network (N/A)
Cancer Australia (1123924)
Cancer Institute NSW (2017/CDF005)
Australian Government (Research Training Program)
- License Information
-
More Information
Article History
Received: 15 June 2020
Accepted: 17 July 2020
First Online: 18 August 2020
Ethics approval and consent to participate
: Ethical approval has been granted for this study by the Royal Prince Alfred Hospital Human Research Ethics Committee (ref HREC/17/RPAH/542). Site-specific governance will be obtained for each site prior to commencing study activities, and individual consent will be obtained prior to participation in study activities.
: Not applicable
: Karen Canfell is co-Principal Investigator of an unrelated trial of cervical screening, funded by the Victorian Cytology Service (VCS), that has received equipment and funding from Roche Molecular Systems, which also manufactures assays for genetic testing that determine access to targeted therapies for colorectal cancer.
